Arete Wealth Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.63M Sell
19,683
-279
-1% -$23.1K 0.12% 183
2025
Q1
$1.62M Buy
19,962
+42
+0.2% +$3.41K 0.12% 170
2024
Q4
$1.79M Sell
19,920
-238
-1% -$21.4K 0.13% 167
2024
Q3
$1.98M Sell
20,158
-1,698
-8% -$167K 0.17% 121
2024
Q2
$2.01M Buy
21,856
+440
+2% +$40.5K 0.17% 126
2024
Q1
$2.03M Sell
21,416
-26
-0.1% -$2.47K 0.19% 128
2023
Q4
$1.91M Buy
+21,442
New +$1.91M 0.15% 145
2023
Q3
Sell
-6,974
Closed -$580K 737
2023
Q2
$580K Sell
6,974
-27
-0.4% -$2.25K 0.05% 332
2023
Q1
$534K Buy
7,001
+505
+8% +$38.5K 0.04% 332
2022
Q4
$539M Buy
6,496
+33
+0.5% +$2.74M 0.05% 314
2022
Q3
$513K Sell
6,463
-8,867
-58% -$704K 0.05% 292
2022
Q2
$1.18M Buy
15,330
+8,376
+120% +$647K 0.12% 130
2022
Q1
$625K Buy
6,954
+45
+0.7% +$4.04K 0.05% 244
2021
Q4
$769K Sell
6,909
-1,239
-15% -$138K 0.07% 218
2021
Q3
$1.03M Buy
8,148
+140
+2% +$17.6K 0.11% 165
2021
Q2
$1.02M Buy
8,008
+355
+5% +$45.3K 0.14% 137
2021
Q1
$1.05M Sell
7,653
-596
-7% -$81.5K 0.13% 155
2020
Q4
$1.16M Sell
8,249
-4,906
-37% -$688K 0.16% 133
2020
Q3
$1.46M Buy
13,155
+4,946
+60% +$550K 0.22% 109
2020
Q2
$919K Buy
8,209
+4,212
+105% +$472K 0.16% 153
2020
Q1
$310K Sell
3,997
-633
-14% -$49.1K 0.06% 239
2019
Q4
$440K Buy
4,630
+225
+5% +$21.4K 0.08% 250
2019
Q3
$336K Hold
4,405
0.06% 278
2019
Q2
$386K Sell
4,405
-119
-3% -$10.4K 0.07% 261
2019
Q1
$410K Buy
4,524
+253
+6% +$22.9K 0.09% 239
2018
Q4
$306K Sell
4,271
-3,107
-42% -$223K 0.07% 269
2018
Q3
$707K Buy
7,378
+566
+8% +$54.2K 0.16% 153
2018
Q2
$648K Hold
6,812
0.15% 160
2018
Q1
$598K Buy
6,812
+110
+2% +$9.66K 0.2% 138
2017
Q4
$569K Buy
6,702
+791
+13% +$67.2K 0.19% 150
2017
Q3
$512K Buy
5,911
+1,862
+46% +$161K 0.2% 147
2017
Q2
$312K Buy
+4,049
New +$312K 0.14% 183